Physician profile
Stephen S Zouzoulas
NPI 1033140892
$244,445.35
in general payments reported to CMS, 2019-2025
27 companies · $72K in 2025
The $72K reported for 2025 was more than what 95% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $17K · 2021: $9,447 · 2022: $19K · 2023: $55K · 2024: $27K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $120K · Travel and Lodging: $12K · Food and Beverage: $12K · Consulting Fee: $9,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $120,103.69 |
| Travel and Lodging | $12,155.52 |
| Food and Beverage | $11,635.80 |
| Consulting Fee | $9,912.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $128,275.69 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $59,020.07 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Novartis Pharmaceuticals Corporation | $42,144.51 | 2019-2025 | |
| Cvrx, INC. | $4,204.07 | 2022-2025 | Barostim Neo System |
| Biotronik INC. | $3,974.09 | 2023-2024 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Amvia Edge |
| Medicure Pharma INC. | $1,937.81 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,090.97 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $1,054.16 | 2022-2025 | Assure Wcd |
| Abiomed | $590.74 | 2019-2025 | Impella |
| Boston Scientific Corporation | $346.82 | 2020-2025 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $255.05 | 2019-2024 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $232.38 | 2024 | Arcalyst |
| Lilly USA, LLC | $195.61 | 2019-2023 | Taltz |
| Procyrion, INC. | $151.45 | 2024 | |
| Paragonix Technologies, INC. | $138.20 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $125.25 | 2021 | |
| Janssen Biotech, INC. | $123.59 | 2024 | Tremfya |
| Pfizer INC. | $109.98 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $105.05 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $86.66 | 2019 | |
| Medtronic, INC. | $72.23 | 2023 | Cobalt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $57.87 | 2022-2023 | Verquvo |
| Medtronic Vascular, INC. | $37.94 | 2019 | |
| Endotronix, INC. | $34.84 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Becton, Dickinson and Company | $33.00 | 2025 | Swan-Ganz |
| Impulse Dynamics (USA) INC. | $24.53 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.79 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Zouzoulas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.